Business- Page 70

Eligible U.S. Feedonomics customers can now use the Merchant Workspace to connect their catalogs to Shop Direct and reach shoppers searching for their products AUSTIN, Texas, Nov. 04, 2026 (GLOBE NEWSWIRE) —

SAN DIEGO, Nov. 04, 2026 (GLOBE NEWSWIRE) — Daré Bioscience, Inc. (NASDAQ: DARE), a purpose-driven health biotech company solely focused on closing the gap in women’s health between promising science and real-world

Investors include ARCH Venture Partners, Adage Capital Management LP, Caligan Partners LP, RTW Investments, a leading mutual fund and other new and existing institutional investors. Ronde-cel, a next-generation CD19/CD20 CAR T-cell product

Updated interim Phase 1 data for oral WEE1 inhibitor APR-1051 to be featured in an oral presentation at the 38th EORTC-NCI-AACR Symposium (ENA 2026) in Barcelona on November 20, 2026APR-1051 Phase 1

SEATTLE, Nov. 04, 2026 (GLOBE NEWSWIRE) — Parabolic Technologies, Inc. (Nasdaq: PARA) (the “Company”), a leading AI-powered agentic applications technology company, today announced the pricing of a firm commitment underwritten public offering

Repeat order underscores demand for full-fidelity data at the scale required to train foundation AI models in radiology MINNEAPOLIS, Nov. 04, 2026 (GLOBE NEWSWIRE) — OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet,” the “Company,”

Combined revenue from two facilities is approximately $750,000 FREDERICK, Md., Nov. 04, 2026 (GLOBE NEWSWIRE) — TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, today

DENVER, Nov. 04, 2026 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transformational treatments for critically ill patients facing organ failure and potential loss of

The study is evaluating the combination in patients with MTAP-deleted pancreatic cancer and MTAP-deleted/RAS mutant non-small cell lung cancer BOSTON and SAN DIEGO, Nov. 04, 2026 (GLOBE NEWSWIRE) — Tango Therapeutics, Inc.

Management to Discuss Updated Preliminary Economic Assessment for the CuMo Project, Including After-Tax NPV of US$1.88 Billion, 18.5% IRR and 46-Year Mine Life BOISE, Idaho, Nov. 04, 2026 (GLOBE NEWSWIRE) — Idaho